Gennex Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 138.96 million compared to INR 165.05 million a year ago. Revenue was INR 146.24 million compared to INR 166.83 million a year ago. Net income was INR 10.85 million compared to INR 7.9 million a year ago. Basic earnings per share from continuing operations was INR 0.067 compared to INR 0.062 a year ago. Diluted earnings per share from continuing operations was INR 0.067 compared to INR 0.062 a year ago.
For the nine months, sales was INR 469.46 million compared to INR 410.36 million a year ago. Revenue was INR 487.58 million compared to INR 413.74 million a year ago. Net income was INR 28.84 million compared to INR 28.5 million a year ago. Basic earnings per share from continuing operations was INR 0.179 compared to INR 0.225 a year ago. Diluted earnings per share from continuing operations was INR 0.179 compared to INR 0.225 a year ago.